Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Huangqi Guizhi Wuwu decoction + Neixiao pill is a combination therapy consisting of two Traditional Chinese Medicine (TCM) formulations. **Huangqi Guizhi Wuwu decoction** is a classic formula originating from the *Jingui Yaolue*, traditionally composed of *Astragalus membranaceus* (Huangqi), *Cinnamomum cassia* (Guizhi), *Paeonia lactiflora* (Shaoyao), *Zingiber officinale* (Shengjiang), and *Ziziphus jujuba* (Dazao); it is primarily used to tonify Qi, harmonize Ying and Wei, and warm the meridians. **Neixiao pill** (often referring to Neixiao Luoli Wan) is a formulation used to soften hardness, dissipate nodules, and reduce swelling, typically containing ingredients like *Prunella vulgaris* and *Scrophularia ningpoensis*. This combination is clinically investigated for the treatment of postoperative upper limb lymphedema in breast cancer patients, where it aims to promote lymphatic circulation, reduce limb circumference, and improve patient quality of life through anti-inflammatory and fluid-regulating effects.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on huangqi guizhi wuwu decoction + neixiao pill.